Follow
C Jackaman
C Jackaman
Verified email at curtin.edu.au
Title
Cited by
Cited by
Year
Blood–brain barrier dysfunction developed during normal aging is associated with inflammation and loss of tight junctions but not with leukocyte recruitment
M Elahy, C Jackaman, JCL Mamo, V Lam, SS Dhaliwal, C Giles, D Nelson, ...
Immunity & Ageing 12, 1-9, 2015
2952015
IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2
C Jackaman, CS Bundell, BF Kinnear, AM Smith, P Filion, D van Hagen, ...
The Journal of Immunology 171 (10), 5051-5063, 2003
2412003
Aging and cancer: The role of macrophages and neutrophils
C Jackaman, F Tomay, L Duong, NBA Razak, FJ Pixley, P Metharom, ...
Ageing research reviews 36, 105-116, 2017
2102017
Targeting macrophages rescues age‐related immune deficiencies in C57 BL/6J geriatric mice
C Jackaman, HG Radley‐Crabb, Z Soffe, T Shavlakadze, MD Grounds, ...
Aging cell 12 (3), 345-357, 2013
1422013
Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8+ T cells in vivo
C Jackaman, D Majewski, SA Fox, AK Nowak, DJ Nelson
Cancer Immunology, Immunotherapy 61, 2343-2356, 2012
1032012
Rescue of skeletal muscle á-actin–null mice by cardiac (fetal) á-actin
KJ Nowak, G Ravenscroft, C Jackaman, A Filipovska, SM Davies, EM Lim, ...
Journal of cell biology 185 (5), 903-915, 2009
952009
Deliberately provoking local inflammation drives tumors to become their own protective vaccine site
C Jackaman, AM Lew, Y Zhan, JE Allan, B Koloska, PT Graham, ...
International immunology 20 (11), 1467-1479, 2008
782008
Mouse models of dominant ACTA1 disease recapitulate human disease and provide insight into therapies
G Ravenscroft, C Jackaman, S Bringans, JM Papadimitriou, LM Griffiths, ...
Brain 134 (4), 1101-1115, 2011
712011
Mouse models of dominant ACTA1 disease recapitulate human disease and provide insight into therapies
G Ravenscroft, C Jackaman, S Bringans, JM Papadimitriou, LM Griffiths, ...
Brain 134 (4), 1101-1115, 2011
712011
CD40‐activated B cells contribute to mesothelioma tumor regression
C Jackaman, S Cornwall, PT Graham, DJ Nelson
Immunology and cell biology 89 (2), 255-267, 2011
602011
Dissociated flexor digitorum brevis myofiber culture system—a more mature muscle culture system
G Ravenscroft, KJ Nowak, C Jackaman, S Clément, MA Lyons, ...
Cell motility and the cytoskeleton 64 (10), 727-738, 2007
592007
Chronic stress and A lzheimer's disease: the interplay between the hypothalamic–pituitary–adrenal axis, genetics and microglia
A Milligan Armstrong, T Porter, H Quek, A White, J Haynes, C Jackaman, ...
Biological Reviews 96 (5), 2209-2228, 2021
512021
Rapid copper acquisition by developing murine mesothelioma: decreasing bioavailable copper slows tumor growth, normalizes vessels and promotes T cell infiltration
A Crowe, C Jackaman, KM Beddoes, B Ricciardo, DJ Nelson
PLoS One 8 (8), e73684, 2013
502013
Murine mesothelioma induces locally-proliferating IL-10+TNF-á+CD206CX3CR1+ M3 macrophages that can be selectively depleted by chemotherapy or …
C Jackaman, TL Yeoh, ML Acuil, JK Gardner, DJ Nelson
Oncoimmunology 5 (6), e1173299, 2016
482016
Multiple Osmotic Stress Responses in Acidihalobacter prosperus Result in Tolerance to Chloride Ions
M Dopson, DS Holmes, M Lazcano, TJ McCredden, CG Bryan, ...
Frontiers in Microbiology 7, 2132, 2017
472017
Macrophage function in the elderly and impact on injury repair and cancer
L Duong, HG Radley, B Lee, DE Dye, FJ Pixley, MD Grounds, DJ Nelson, ...
Immunity & Ageing 18, 1-11, 2021
442021
Macrophage depletion in elderly mice improves response to tumor immunotherapy, increases anti-tumor T cell activity and reduces treatment-induced cachexia
L Duong, HG Radley-Crabb, JK Gardner, F Tomay, DE Dye, MD Grounds, ...
Frontiers in Genetics 9, 526, 2018
422018
Mesothelioma tumor cells modulate dendritic cell lipid content, phenotype and function
JK Gardner, CDS Mamotte, P Patel, TL Yeoh, C Jackaman, DJ Nelson
PLoS One 10 (4), e0123563, 2015
422015
Aged neutrophils accumulate in lymphoid tissues from healthy elderly mice and infiltrate T‐and B‐cell zones
F Tomay, K Wells, L Duong, JW Tsu, DE Dye, HG Radley‐Crabb, ...
Immunology and cell biology 96 (8), 831-840, 2018
392018
Intratumoral interleukin-2/agonist CD40 antibody drives CD4+-independent resolution of treated-tumors and CD4+-dependent systemic and memory responses
C Jackaman, DJ Nelson
Cancer Immunology, Immunotherapy 61, 549-560, 2012
382012
The system can't perform the operation now. Try again later.
Articles 1–20